Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

Summary

The purpose of this study is to evaluate the safety and efficacy of three doses of topical NEOSH101 applied once-daily (qd) for 16 weeks in men with thinning hair in the top and center of the scalp (Norwood/Hamilton grades III-IV androgenetic alopecia). Four equally sized treatment groups (35 men each) will receive either NEOSH101 0.5%, NEOSH101 1.0%, NEOSH101 2.0% or placebo. A 12-week observation period will follow the treatment period.

Timeline

Start

2007-05

Primary completion

2008-02

Completion

—

Drugs

Indications